Subscriber Only
Middlemen Play Gatekeeper in Battle to Curb Soaring Drug Costs
- U.S. insurers, drug plans more agressive at getting discounts
- Upcoming drugs for migraine, NASH are a ‘watch out:’ insurer

Photographer: Andrey Rudakov/Bloomberg

Photographer: Andrey Rudakov/Bloomberg